Invention Application
- Patent Title: NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
-
Application No.: US17479244Application Date: 2021-09-20
-
Publication No.: US20220162216A1Publication Date: 2022-05-26
- Inventor: Guoqiang Wang , Ruichao Shen , Yong He , Xuri Gao , Jun Ma , Xuechao Xing , Hui Cao , Joseph D. Panarese , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Main IPC: C07D487/10
- IPC: C07D487/10

Abstract:
The present invention discloses compounds of Formula (Ia), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (Ia) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US11384090B2 Spiropyrrolidine derived antiviral agents Public/Granted day:2022-07-12
Information query